Earnings & Reporting

Petco is refinancing $1.5B in debt to extend maturities while reaffirming its financial outlook. Is this a sign of strength or underlying strain?

Retailers are losing billions to refund abuse, but new AI tools can spot fraud in real time, protecting revenue without punishing your best customers.

Promising new 96-week data shows Vir's therapy could redefine care for severe hepatitis delta, as its oncology pipeline and financial runway also advance.

The pediatric device firm posted 15% growth to $236.1M in 2025, issuing strong 2026 guidance fueled by its specialty bracing and European expansion.

The burger chain posted positive sales and aggressive 2026 growth plans, navigating weather woes and inflation with new menu items and operational tweaks.

Teladoc Health's enhanced service integrates specialist consults and data analytics, moving beyond urgent care to reshape healthcare costs and patient outcomes.

The western wear retailer posted a 16% sales jump and a nearly 20% surge in e-commerce, signaling robust growth ahead of its ICR Conference appearance.

As Celanese prepares to report its Q4 2025 results, investors and analysts are watching for signs of recovery and strategic clarity in a volatile market.

The fast-food giant makes a significant debt repayment as part of its 'JACK on Track' plan, signaling a strategic pivot to fix its balance sheet.

The SMX World Championship Final finds a new home at a conservation-focused arena in a landmark deal with Bass Pro Shops, blending motorsports and nature.

The automotive giant honored its top vendors, signaling that deep strategic partnerships are crucial to its ongoing operational and financial transformation.

Gartner recognizes Jamf as a Leader in endpoint management, highlighting the growing dominance of specialized, Apple-centric solutions in the enterprise.

CVS Health is set to reveal its 2025 results. Will its integrated strategy pay off amid rising costs, PBM scrutiny, and a key Aetna turnaround?

Newly-formed materials giant Magnera reports Q1 results on Feb 5. Investors eye its path to profitability while the industry watches for key market signals.

The oil and gas firm raised its quarterly payout to $0.40/share, rewarding investors and underscoring its financial health and disciplined strategy.

After a major business sale, Elutia is launching NXT-41x, an antibiotic biomatrix designed to combat the high rate of infection in breast reconstruction.

Rigetti Computing pushes back its Cepheus-1-108Q launch to Q1 2026, a move that rattled investors but underscores the quantum industry's tough race for fidelity.

With its first MASH drug a success, Madrigal aims to redefine treatment by combining it with a newly licensed Pfizer asset. Is this the future?

The fintech platform grew twice as fast as the overall market in 2025, fueled by tech innovation and a surge in multi-protocol trading adoption.

Indonesia Energy Corp. starts pre-drilling for two new wells in Sumatra, a key move in its growth strategy and a boost for national energy security.